|
Market Closed -
Nasdaq
16:00:00 2026-10-13 EDT
|
5-day change | 1st Jan Change | ||
| 26.05 USD | -2.65% |
|
+0.54% | -2.73% |
| 08-18 | Barclays Adjusts Price Target on Amphastar Pharmaceuticals to $23 From $20, Maintains Equalweight Rating | MT |
| 08-07 | Amphastar Pharmaceuticals, Inc., Q2 2026 Earnings Call, Aug 06, 2026 |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.65% | +0.54% | +9.55% | +35.04% | -2.73% | +10.80% | -43.07% | +35.54% | +42.04% | 1.14B | |
| -1.36% | +0.78% | +4.55% | -1.30% | +8.54% | +42.36% | +91.48% | +393.36% | +1,358.14% | 1,054B | |
| -5.73% | -2.42% | -6.39% | -3.55% | +20.13% | +30.23% | +58.50% | +56.16% | +110.22% | 636B | |
| -2.40% | +2.88% | +6.71% | +10.63% | +20.08% | +19.13% | +85.43% | +152.80% | +348.67% | 497B | |
| -2.39% | +0.03% | -1.35% | +14.47% | +34.89% | +65.67% | +36.51% | +79.84% | +127.13% | 359B | |
| -0.06% | +2.86% | +4.53% | +8.80% | +9.63% | +24.03% | +41.07% | +0.76% | +53.76% | 345B | |
| -0.55% | +1.81% | +6.48% | -4.24% | +8.85% | +14.16% | +36.31% | +55.95% | +60.03% | 273B | |
| -1.08% | -0.52% | +1.61% | -5.66% | -13.73% | -6.51% | +8.40% | +34.34% | +140.30% | 246B | |
| -1.13% | +2.54% | +9.41% | +14.53% | +26.13% | +41.19% | +45.32% | +102.76% | +151.29% | 226B | |
| -1.67% | +2.56% | +2.92% | +12.57% | +20.51% | +25.13% | +90.50% | +118.72% | +102.46% | 187B | |
| +0.10% | +4.52% | -7.16% | -20.88% | -21.09% | -31.29% | -64.18% | -20.30% | +93.19% | 169B | |
| -0.11% | +3.16% | +2.34% | +15.89% | +13.94% | +14.72% | -11.65% | -31.51% | -13.40% | 162B | |
| -4.30% | -3.40% | -5.86% | +1.03% | +7.03% | +19.11% | +30.79% | +167.57% | +502.31% | 129B | |
| -1.58% | -4.90% | -10.95% | -4.50% | +5.06% | +30.16% | +0.35% | -0.70% | +12.80% | 118B | |
| +0.64% | +4.36% | +9.12% | +18.42% | +17.26% | +25.00% | +107.95% | +382.73% | +493.50% | 111B | |
| -1.20% | +0.18% | -3.44% | -8.25% | -14.48% | -15.95% | -31.57% | -15.31% | +3.79% | 95.82B | |
| -1.02% | -0.71% | -0.99% | -10.26% | -3.92% | +7.71% | +16.09% | +0.10% | -17.51% | 93.75B | |
| +1.17% | +15.36% | +50.20% | +222.71% | +633.30% | +708.71% | +119.99% | -32.74% | - | 85.33B | |
| -1.27% | +1.95% | -3.63% | +13.58% | -2.43% | +35.03% | -10.30% | +37.65% | +100.41% | 76.17B | |
| -0.76% | -1.01% | +4.68% | -1.61% | +12.23% | +16.86% | -8.54% | -28.15% | +44.42% | 67.34B | |
| Average | -1.28% | +2.36% | +3.62% | +15.37% | +38.96% | +53.81% | +29.97% | +74.48% | +195.45% | 246.53B | |
| Weighted average by Cap. | -1.25% | +2.30% | +2.44% | +6.46% | +22.59% | +38.70% | +51.31% | +137.22% | +410.17% |
- Stock Market
- Stocks
- AMPH Stock
- Sector Amphastar Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
